-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 AYHmX7npNcSH2kizZQJgcySJS1PhuQeXkf9dggGp3M6c2HGQ/cobMi+24ZSFz8ps
 3+7+6OosgQtX3EnD7qA5vA==

<SEC-DOCUMENT>0000911420-07-000128.txt : 20070215
<SEC-HEADER>0000911420-07-000128.hdr.sgml : 20070215
<ACCEPTANCE-DATETIME>20070215205037
ACCESSION NUMBER:		0000911420-07-000128
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070207
FILED AS OF DATE:		20070215
DATE AS OF CHANGE:		20070215

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			KAY CHRISTINA
		CENTRAL INDEX KEY:			0001064901

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31668
		FILM NUMBER:		07629217

	BUSINESS ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205
		BUSINESS PHONE:		9739260816

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTEGRATED BIOPHARMA INC
		CENTRAL INDEX KEY:			0001016504
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				133035216
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	BUSINESS ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205
		BUSINESS PHONE:		9739260816

	MAIL ADDRESS:	
		STREET 1:		201 ROUTE 22
		CITY:			HILLSIDE
		STATE:			NJ
		ZIP:			07205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTEGRATED HEALTH TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20020912

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEM INTERNATIONAL INC
		DATE OF NAME CHANGE:	19960716
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>p238307986_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2007-02-07</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001016504</issuerCik>
        <issuerName>INTEGRATED BIOPHARMA INC</issuerName>
        <issuerTradingSymbol>INBP</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001064901</rptOwnerCik>
            <rptOwnerName>KAY CHRISTINA</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O INTEGRATED BIOPHARMA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>225 LONG AVE</rptOwnerStreet2>
            <rptOwnerCity>HILLSIDE</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07205</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Vice President</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Restricted Stock Unit</value>
                <footnoteId id="F1"/>
            </securityTitle>
            <transactionDate>
                <value>2007-02-07</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>34000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>6.80</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>702801</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Stock Options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.80</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2007-02-07</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>16000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2017-02-07</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>16000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>616666</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On February 7, 2007, the Reporting Person was granted 34,000 Restricted Stock Units as compensation for serving as a director
 and officer of the Issuer.  Each Restricted Stock Unit consists of a right to the issuance of one share of common stock, par
 value $.01 (&quot;Common Stock&quot;).  The Restricted Stock Units are subject to a three-year vesting period.  None of the Restricted
 Stock Units are included in the amount of securities beneficially owned following the reported transaction in column 5, as
 none of the Restricted Stock Units will vest in the next 60 days.</footnote>
        <footnote id="F2">On February 7, 2007, the Reporting Person was granted a stock option to purchase 16,000 shares of Common Stock at an exercise
 price of $6.80 per share as compensation for serving as a director and officer of the Issuer.  These stock options are
 subject to a three-year vesting period, with an initial annual vesting date of December 20, 2007.  None of these stock
 options are included in the amount of derivative securities beneficially owned following the reported transaction in column
 9, as none of the stock options will vest in the next 60 days.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/Christina M. Kay</signatureName>
        <signatureDate>2007-02-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----